Heizmann B, Ebert K, Fehrenbach K, Janowska I, Chan S, Tanriver Y, Minguet S, Schamel WW. (2024) Kidins220 and Aiolos promote thymic iNKT cell development by reducing TCR signals. Sci Adv, doi: 10.1126/sciadv.adj2802.
Schneider J, Wobser R, Kühn W, Wagner D, Tanriver Y, Walz G. (2023) Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients. BMC Nephrol, doi: 10.1186/s12882-023-03154-w.
Thelen B, Schipperges V, Knörlein P, Hummel JF, Arnold F, Kupferschmid L, Klose CSN, Arnold SJ, Boerries M, Tanriver Y. (2023) Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4+ T cells. Front Immunol, doi: 10.3389/fimmu.2023.1058267.
Zeiser R, Warnatz K, Rosshart S, Sagar, Tanriver Y. (2022) GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity. Eur J Immunol, doi: 10.1002/eji.202149530.
Rickassel C, Gnirck AC, Shaikh N, Adamiak V, Waterhölter A, Tanriver Y, Neumann K, Huber TB, Gasteiger G, Panzer U, Turner JE. (2022) Conventional NK Cells and Type 1 Innate Lymphoid Cells Do Not Influence Pathogenesis of Experimental Glomerulonephritis. J Immunol, doi: 10.4049/jimmunol.2101012.
Tanriver U, Emmerich F, Hummel JF, Jänigen B, Panning M, Arnold F, Tanriver Y. (2022) IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study. Clin Transplant, doi: 10.1111/ctr.14663.
Kemming J, Gundlach S, Panning M, Huzly D, Huang J, Lütgehetmann M, Pischke S, Schulze Zur Wiesch J, Emmerich F, Llewellyn-Lacey S, Price DA, Tanriver Y, Warnatz K, Boettler T, Thimme R, Hofmann M, Fischer N, Neumann-Haefelin C. (2022) Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection. J Hepatol, doi: 10.1016/j.jhep.2022.05.019.
Arnold F, Huzly D, Tanriver Y, Welte T. (2022) Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease. BMC Infect Dis, doi: 10.1186/s12879-022-07722-7.
Weigang S, Fuchs J, Zimmer G, Schnepf D, Kern L, Beer J, Luxenburger H, Ankerhold J, Falcone V, Kemming J, Hofmann M, Thimme R, Neumann-Haefelin C, Ulferts S, Grosse R, Hornuss D, Tanriver Y, Rieg S, Wagner D, Huzly D, Schwemmle M, Panning M, Kochs G. (2021) Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Nat Commun, doi: 10.1038/s41467-021-26602-3.
Hummel JF, Zeis P, Ebert K, Fixemer J, Konrad P, Schachtrup C, Arnold SJ, Grün D and Tanriver Y. (2020) Single-cell RNA-sequencing identifies the developmental trajectory of C-Myc-dependent NK1.1- T-bet+ intraepithelial lymphocyte precursors Mucosal Immunol, doi: 10.1038/s41385-019-0220-y.
Fixemer J, Hummel JF, Arnold F, Klose CSN, Hofherr A, Weissert K, Kögl T, Köttgen M, Arnold SJ, Aichele P, Tanriver Y. (2020) Eomes cannot replace its paralog T-bet during expansion and differentiation of CD8 effector T cells PLoS Pathog, doi: 10.1371/journal.ppat.1008870.
Sagar, Pokrovskii M, Herman JS, Naik S, Sock E, Zeis P, Lausch U, Wegner M, Tanriver Y, Littman DR, Grün D. (2020) Deciphering the regulatory landscape of fetal and adult Gamma Delta T-cell development at single-cell resolution EMBO J, doi: 10.15252/embj.2019104159.
Arnold F, Westermann L, Rieg S, Neumann-Haefelin E, Biever PM, Walz G, Kalbhenn J, Tanriver Y. (2020) Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study. BMC Nephrol, doi: 10.1186/s12882-020-02150-8.
Guendel F, Kofoed-Branzk M, Gronke K, Tizian C, Witkowski M, Cheng HW, Heinz GA, Heinrich F, Durek P, Norris PS, Ware CF, Ruedl C, Herold S, Pfeffer K, Hehlgans T, Waisman A, Becher B, Giannou AD, Brachs S, Ebert K, Tanriver Y, Ludewig B, Mashreghi MF, Kruglov AA, Diefenbach A. (2020) Group 3 Innate Lymphoid Cells Program a Distinct Subset of IL-22BP-Producing Dendritic Cells Demarcating Solitary Intestinal Lymphoid Tissues. Immunity, doi: 10.1016/j.immuni.2020.10.012.
Rafei-Shamsabadi DA, Klose CSN, Halim TYF, Tanriver Y and Jakob T. (2019) Context Dependent Role of Type 2 Innate Lymphoid Cells in Allergic Skin Inflammation Front Immunol, doi: 10.3389/fimmu.2019.02591.
Ye L, Schnepf D, Becker J, Ebert K, Tanriver Y, Bernasconi V, Gad HH, Hartmann R, Lycke N and Staeheli P. (2019) Interferon-lambda enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin Nat Immunol, doi: 10.1038/s41590-019-0345-x.
Mathew NR, Baumgartner F, Braun L, ..., Tanriver Y, ..., Pearce E, Blazar BR and Zeiser R. (2018) Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells Nat Med, doi: 10.1038/nm0418-526c.
Rafei-Shamsabadi DA, van de Poel S, Dorn B, Kunz S, Martin SF, Klose CSN, Arnold SJ, Tanriver Y, Ebert K, Diefenbach A, Halim TYF, McKenzie ANJ and Jakob T. (2018) Lack of Type 2 Innate Lymphoid Cells Promotes a Type I-Driven Enhanced Immune Response in Contact Hypersensitivity J Invest Dermatol, doi: 10.1016/j.jid.2018.03.001.
Mathew NR, Baumgartner F, Braun L, ..., Tanriver Y, ...,Pearce E, Blazar BR and Zeiser R. (2018) Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells Nat Med, doi: 10.1038/nm.4484.
Klose CSN, Hummel JF, Faller L, d'Hargues Y, Ebert K and Tanriver Y. (2018) A committed postselection precursor to natural TCRalphabeta+ intraepithelial lymphocytes Mucosal Immunol, doi: 10.1038/mi.2017.54.
Friedmann D, Keller B, Harder I, Schupp J, Tanriver Y, Unger S and Warnatz K. (2017) Preferential Reduction of Circulating Innate Lymphoid Cells Type 2 in Patients with Common Variable Immunodeficiency with Secondary Complications Is Part of a Broader Immune Dysregulation J Clin Immunol, doi: 10.1007/s10875-017-0444-0.
Probst S, Daza RA, Bader N, Hummel JF, Weiß M, Tanriver Y, Hevner RF and Arnold SJ. (2017) A dual-fluorescence reporter in the Eomes locus for live imaging and medium-term lineage tracing Genesis, doi: 10.1002/dvg.23043.
Powell JJ, Thomas-McKay E, Thoree V, Robertson J, Hewitt RE, Skepper JN, Brown A, Hernandez-Garrido JC, Midgley PA, Gomez-Morilla I, Grime GW, Kirkby KJ, Mabbott NA, Donaldson DS, Williams IR, Rios D, Girardin SE, Haas CT, Bruggraber SF, Laman JD, Tanriver Y, Lombardi G, Lechler R, Thompson RP, Pele LC (2015) An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cells Nat Nanotechnol 10, 361-369
C. S. Klose, K. Blatz, Y. d'Hargues, P. P. Hernandez, M. Kofoed-Nielsen, J. F. Ripka, K. Ebert, S. J. Arnold, A. Diefenbach, E. Palmer and Y. Tanriver (2014) The transcription factor T-bet is induced by IL-15 and thymic agonist selection and controls CD8 alpha alpha(+) intraepithelial lymphocyte development Immunity 41, 230-243
C. S. Klose, M. Flach, L. Mohle, L. Rogell, T. Hoyler, K. Ebert, C. Fabiunke, D. Pfeifer, V. Sexl, D. Fonseca-Pereira, R. G. Domingues, H. Veiga-Fernandes, S. J. Arnold, M. Busslinger, I. R. Dunay, Y. Tanriver and A. Diefenbach (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages Cell 157, 340-356
Y. Tanriver and A. Diefenbach (2014) Transcription factors controlling development and function of innate lymphoid cells Int Immunol 26, 119-128
I. M. Pimeisl, Y. Tanriver, R. A. Daza, F. Vauti, R. F. Hevner, H. H. Arnold and S. J. Arnold (2013) Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line Genesis 51, 725-733
L. A. Smyth, K. Ratnasothy, A. Moreau, S. Alcock, P. Sagoo, L. Meader, Y. Tanriver, M. Buckland, R. Lechler and G. Lombardi (2013) Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs Immunol 190, 4848-60
C. S. Klose, E. A. Kiss, V. Schwierzeck, K. Ebert, T. Hoyler, Y. d'Hargues, N. Goppert, A. L. Croxford, A. Waisman, Y. Tanriver and A. Diefenbach (2013) A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells Nature 494, 261-5.
C. S. Klose, T. Hoyler, E. A. Kiss, Y. Tanriver and A. Diefenbach (2012) Transcriptional control of innate lymphocyte fate decisions Curr Opin Immunol 24, 290-6.
R. Tavare, P. Sagoo, G. Varama, Y. Tanriver, A. Warely, S. S. Diebold, R. Southworth, T. Schaeffter, R. I. Lechler, R. Razavi, G. Lombardi and G. E. Mullen (2011) Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination PLoS One 6, e19662.
H. Shariff, Y. Tanriver, K. L. Brown, L. Meader, R. Greenlaw, N. Mamode and S. Jurcevic (2010) Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients Transplantation 90, 270-8.
Y. Tanriver, M. J. Betz, L. Nibbe, T. Pfluger, F. Beuschlein and M. Z. Strowski (2010) Sepsis and cardiomyopathy as rare clinical manifestations of pheochromocytoma--two case report studies Exp Clin Endocrinol Diabetes 118, 747-53.
Y. Tanriver, A. Martin-Fontecha, K. Ratnasothy, G. Lombardi and R. Lechler (2009) Superantigen-activated regulatory T cells inhibit the migration of innate immune cells and the differentiation of naive T cells J Immunol 183, 2946-56.
J. Y. Tsang, Y. Tanriver, S. Jiang, E. Leung, K. Ratnasothy, G. Lombardi and R. Lechler (2009) Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression Transpl Immunol 21, 203-9.
J. Y. Tsang, Y. Tanriver, S. Jiang, S. A. Xue, K. Ratnasothy, D. Chen, H. J. Stauss, R. P. Bucy, G. Lombardi and R. Lechler (2008) Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice J Clin Invest 118, 3619-28.
J. Tsang, S. Jiang, Y. Tanriver, E. Leung, G. Lombardi and R. I. Lechler (2006) In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity Int Immunopharmacol 6, 1883-8.
R. Schindler, S. G. Tullius, Y. Tanriver, K. Noack, Y. Qun, J. S. Jurgensen and U. Frei (2003) Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy Kidney Int 63, 2302-8.
R. Schindler, Y. Tanriver and U. Frei (2000) Hypertension and allograft nephropathy--cause, consequence, or both? Nephrol Dial Transplant 15, 8-10.
UNI Freiburg Universitätsklinikum Freiburg DFG